Guilherme S. Ramos

Belo Horizonte, MG 31270901, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Supramolecular assemblies from antimony(V) complexes for the treatment of leishmaniasis.

Supramolecular assemblies from antimony(V) complexes for the treatment of leishmaniasis.

Journal: Biophysical reviews

Published: March 28, 2023

Liposomal Amphotericin B for Treatment of Leishmaniasis: From the Identification of Critical Physicochemical Attributes to the Design of Effective Topical and Oral Formulations.

Liposomal Amphotericin B for Treatment of Leishmaniasis: From the Identification of Critical Physicochemical Attributes to the Design of Effective Topical and Oral Formulations.

Journal: Pharmaceutics

Published: November 15, 2022

Nanoassemblies from Amphiphilic Sb Complexes Target Infection Sites in Models of Visceral and Cutaneous Leishmaniases.

Nanoassemblies from Amphiphilic Sb Complexes Target Infection Sites in Models of Visceral and Cutaneous Leishmaniases.

Journal: Pharmaceutics

Published: July 13, 2022

Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes.

Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes.

Journal: Pharmaceutics

Published: March 29, 2022

Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis.

Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis.

Journal: Molecular immunology

Published: September 08, 2021

Antileishmanial activity of fullerol and its liposomal formulation in experimental models of visceral leishmaniasis.

Antileishmanial activity of fullerol and its liposomal formulation in experimental models of visceral leishmaniasis.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 11, 2020

Therapeutic Efficacy of a Mixed Formulation of Conventional and PEGylated Liposomes Containing Meglumine Antimoniate, Combined with Allopurinol, in Dogs Naturally Infected with Leishmania infantum.

Therapeutic Efficacy of a Mixed Formulation of Conventional and PEGylated Liposomes Containing Meglumine Antimoniate, Combined with Allopurinol, in Dogs Naturally Infected with Leishmania infantum.

Journal: Antimicrobial agents and chemotherapy

Published: February 04, 2020

Mixed Formulation of Conventional and Pegylated Meglumine Antimoniate-Containing Liposomes Reduces Inflammatory Process and Parasite Burden in Leishmania infantum-Infected BALB/c Mice.

Mixed Formulation of Conventional and Pegylated Meglumine Antimoniate-Containing Liposomes Reduces Inflammatory Process and Parasite Burden in Leishmania infantum-Infected BALB/c Mice.

Journal: Antimicrobial agents and chemotherapy

Published: May 09, 2017

Gadolinium(III) Complexes with N-Alkyl-N-methylglucamine Surfactants Incorporated into Liposomes as Potential MRI Contrast Agents.

Gadolinium(III) Complexes with N-Alkyl-N-methylglucamine Surfactants Incorporated into Liposomes as Potential MRI Contrast Agents.

Journal: Bioinorganic chemistry and applications

Published: May 11, 2015

Amphiphilic Antimony(V) Complexes for Oral Treatment of Visceral Leishmaniasis.

Amphiphilic Antimony(V) Complexes for Oral Treatment of Visceral Leishmaniasis.

Journal: Antimicrobial agents and chemotherapy

Published: March 30, 2013

Showing 1-10 of 10

Last Updated: 09/26/2026